HR Digest

FEBRUARY 24, 2023

As a project manager for a marketing agency, I noticed a significant increase in my team’s productivity when we transitioned to remote work. Anon, Marketing Industry Improve Employee Satisfaction One of the most significant benefits of remote work is that it can lead to improved employee satisfaction.

Guidelines 100

Guidelines Policies Cost Pharmaceuticals 100

The Horizons Tracker

SEPTEMBER 10, 2021

By contrast, firms operating in areas such as online retail, pharmaceuticals, and information and communications technology, have all thrived. Smaller firms were especially affected by the virus because they rely far more on face-to-face interactions with customers for both marketing and transactions. Face-to-face interactions.

Pharmaceuticals 70

Pharmaceuticals Transportation Retail Long-term 70

Strategy Driven

APRIL 3, 2014

Crafting and writing a branded healthcare executive resume, that differs from the traditional medical resume, can make a significant difference in your executive job search results and improve the opportunities to land that next-level position in pharmaceutical, biotech and medical device industries. You must appeal to all of these audiences.

Tactics 51

Tactics Execution Pharmaceuticals Human Capital 51

The Horizons Tracker

FEBRUARY 22, 2022

It’s a market that is already worth $3.1 billion and is estimated to be worth $48 billion by 2026, with the Covid pandemic driving growth, especially in the healthcare and pharmaceutical industries, but also in sectors such as automotive and defense. “ There are cases with upload speeds of over 1Gbps.

Stephenson 109

Stephenson Wireless Christensen Automotive 109

Strategy Driven

JUNE 22, 2018

When your operational and back office processes are aligned you work efficiently and productively. By adapting your marketing strategy, you will be able to target new audiences for your products and services. Let’s look at the niche markets that you can tap into boost your business’s growth and profitability: Seniors.

Audience 50

Audience Niche Marketing How To Marketing Strategy 50

Strategy Driven

JULY 13, 2011

It turned out that the unit was driving profits by raising prices and cutting marketing and advertising expenditures. Higher prices and reduced advertising created an opening for competitors to take away market share, which they did. So while profits were rising and ROIC was high, market share was declining.

ROIC 62

ROIC Balanced Scorecard Metrics McKinsey 62

Harvard Business Review

JULY 30, 2015

A new research report from the Society of Digital Agencies finds that in the past year there has been a dramatic spike in the number of companies who no longer work with outside marketing agencies — 27 percent, up from 13 percent in the previous year. Marketing activities today generate unprecedented amounts of data.

Marketing 8

Marketing Advertising Trends Brand 8

Harvard Business Review

JUNE 13, 2016

No matter how you look at it, there have been terrible, unintended outcomes from the introduction and marketing of next-generation prescription opioids. Since 1999, three years after OxyContin was unveiled by Purdue Pharmaceuticals, the rate of drug overdoses in the U.S. And what can we learn from it?

Incentives 8

Incentives Pharmaceuticals Crisis P&L 8

Harvard Business Review

JULY 23, 2015

For years, there has been a push within the pharmaceutical industry to move “beyond the pill” — in other words, to build and deploy complementary services and solutions to diversify revenue sources. However, many beyond-the-pill efforts have sputtered or died. Regulatory environment.

Pharmaceuticals 8

Pharmaceuticals Health Care Industry Committee 8

Harvard Business Review

AUGUST 3, 2016

On the other hand, M&As can also strengthen the market power of the combined entity, reducing competition in a way that harms consumers. This is especially true in pharmaceutical markets where new and affordable drugs can improve and even save the lives of many people. What’s the reason for this?

Innovation 8

Innovation Pharmaceuticals Company Price 8

Harvard Business Review

MAY 26, 2016

Operating margins for firms publicly listed in the US show a substantial and sustained rise. Firms engage in political “rent seeking”—lobbying for regulations that provide them sheltered markets—rather than competing on innovation. Profits are up. Corporate valuations are up as well.

Pharmaceuticals 11

Pharmaceuticals Politics Price Chemicals 11

Harvard Business Review

JULY 8, 2016

The difference between displacement (outperforming existing market incumbents at their own game) and disruption (changing the game) is strategically important, no matter how similar the pain they cause is. Drucker Forum 2016: The Entrepreneurial Society. Displacement generally is easier to combat than disruption.

Business Model 10

Business Model Innovation Company Apparel 10

Harvard Business Review

AUGUST 14, 2018

However, they have all failed in China, the world’s largest digital market. Google, for example, has succeeded in dominating many foreign markets that have radically different political systems and cultures (including Indonesia, Thailand, and Saudi Arabia). market on China. market on China.

Competitive Advantage 11

Competitive Advantage Business Model Technology Marketing 11

Harvard Business Review

MAY 20, 2014

financial services sector went from 13,000 of independent banks to half that number, while the top ten banks grew from 20% market share to 60%. As of 2013, the top ten banks had 70% of the market. In pharmaceuticals, the largest company, Pfizer, is the result of decades of mergers. In the guitar business , too.

Pharmaceuticals 11

Pharmaceuticals Banking Chemicals Entrepreneur 11

Strategy Driven

MARCH 18, 2011

In The Essential Advantage : How to Win with a Capabilities-Driven Strategy , Booz & Company’s Paul Leinwand and Cesare Mainardi maintain that success in any market accrues to firms with a coherence premium – a tight match between their strategic direction and the capabilities that make them unique. Let’s go after it.”

Resources 51

Resources Industry System Strategy 51

Harvard Business Review

FEBRUARY 6, 2018

Consider its decision to pursue the market for pharmaceutical distribution, or the recent announcement that it will be teaming up with Berkshire Hathaway and JP Morgan Chase to create joint solutions for reducing the health care spending of more than 1 million employees and their families. .”

Health Care 11

Health Care Retail Operations Insurance 11

Harvard Business Review

NOVEMBER 28, 2017

One of your executives comes to you with a proposal: she wants to lower the quality of service at the restaurants, reduce product safety standards, use deceptive marketing practices, lower employee pay, and adopt worse environmental practices. Why do anti-profit beliefs persist in a market society? But these effects were limited.

Company 8

Company Short-term Long-term Price 8

Strategy Driven

JANUARY 24, 2011

Execution Gap Maker #2: Nokia Nokia’s share of the worldwide market for mobile phones continued to slip in 2010. Why was this once-dominant player unable to execute and maintain its market position? This is a book for the times we live in—and one that for many companies could mean the difference between success and failure.

Execution 67

Execution Company 360-Degree Feedback Cooper 67

Harvard Business Review

AUGUST 8, 2018

As chief executive from 1972 to 1994, Richard Gelb (HBS, 1950) orchestrated Bristol-Myers’ acquisition of Squibb and transformed the firm from a personal care company to a diversified pharmaceutical giant. ” The thinking on diversification later changed, turning into skepticism in the 1970s and outright criticism in the 1980s.

Influence 13

Influence Education Pharmaceuticals Finance 13

Harvard Business Review

OCTOBER 6, 2016

Barbara Kellerman from Harvard, Jeffrey Pfeffer from Stanford, and numerous other experts have pointed out that the development market is filled with fads — slick behavioral models and fun, engaging tools — that don’t really move the needle. But there’s little evidence that much of this works. Insight Center.

Leadership Pipeline 13

Leadership Pipeline Leadership After Action Review Pharmaceuticals 13

Harvard Business Review

OCTOBER 20, 2016

As a practical matter, for example, these changes in the global policy regime are forcing multinational corporations to scale back and sell parts of their international operations. Meanwhile the Institute of International Finance forecasted net capital flows for emerging markets in 2015 would be negative for the first time since 1988.

Globalization 8

Globalization Banking Policies Politics 8

Harvard Business Review

AUGUST 24, 2017

Our analyses controlled for a wide range of the firm characteristics typically used in the statistical analysis of companies: industry, firm size, leverage, profitability, market-to-book ratio, returns, volatility, particular time periods, industry effects, and a host of other factors that might influence litigation.

CEO 8

CEO Accrual Accounting Pharmaceuticals Banking 8

Harvard Business Review

JULY 28, 2015

Let’s look at a few examples of powerful summaries: “Pharmaceutical marketing executive with 20 years of experience creating commercial infrastructures, growing brands, and optimizing product value throughout launch, re-launch, and sunset life cycles across all customer segments—payers, physicians, and patients.

Pharmaceuticals 8

Pharmaceuticals Retail Long-term Industry 8

Harvard Business Review

FEBRUARY 16, 2017

Most businesses wouldn’t survive without driving demand for their products or services, either through marketing and advertising or through involving users so deeply in the design of the product that word of mouth spurs adoption. Develop and fund a sales and marketing capability from the outset. Let’s look at each of these.

Innovation 9

Innovation Rogers NGO Participative 9

Harvard Business Review

NOVEMBER 9, 2011

COOs are relatively common in service industries such as financial services, energy, information technology and telecommunications, but in manufacturing sectors — such as automotive, chemical, and pharmaceutical companies — they are relatively rare. What do you think?

COO 14

COO Sample Telecommunications Automotive 14

Harvard Business Review

MARCH 11, 2013

And today the company has become more open in a number of areas, as the pressures of the market forces are forcing it to open up even further. That can be a powerful marketing technique if you have the market muscle to pull it off. That can be a powerful marketing technique if you have the market muscle to pull it off.

Supply Chain 15

Supply Chain Open-book Software Niche Marketing 15

Harvard Business Review

APRIL 2, 2018

health care system, ranging from expensive imaging for benign medical conditions to routine pre-operative testing before low-risk surgeries like cataract surgery. Examples of significant investments in low-value care services abound in the U.S. Some research estimates that 42% of Medicare beneficiaries receive some form of low-value care.

Health Care 8

Health Care Insurance Pharmaceuticals Incentives 8

Harvard Business Review

JUNE 14, 2017

And ease of access means ease of market entry: Emerging data providers can get on their feet quickly and create new sources of competition. The bulk of HCIT investment supports startups that sell data — clinical or operational information that is otherwise difficult for clients to obtain or to organize. demographics.

Health Care 9

Health Care Levitt Pharmaceuticals Competitive Advantage 9

Harvard Business Review

MAY 7, 2015

What happened is very well documented: they kept running down the maintenance budget, pushing their operating budget to make their numbers. Meanwhile, I had a lot friends and colleagues saying, “The capital markets are a huge problem.” the capital markets are much stickier. Insight Center. The New Ways to Compete.

Short-term 8

Short-term Henderson Long-term Metrics 8

Harvard Business Review

OCTOBER 24, 2014

In addressing the billion-dollar adherence problem, Vitality (since acquired by NANTHEALTH ) considered the interests of the players in the diverse ecosystem, including pharmaceutical companies, retail pharmacies, and health care providers. Operations. Information & technology Operations Organizational culture Product development'

Productivity 8

Productivity Products Company Engineering 8

Harvard Business Review

OCTOBER 26, 2017

The innovation of the Bolognese silk makers was to operate the Lucca machine with a hydraulic wheel, instead of by hand. Bolognese yarns were sold to the doges of Venice or exchanged for spices and salt, and they were also exported to the large international markets, to France, Germany, England and even to the East.

Education 8

Education Pharmaceuticals Innovation Industry 8

Harvard Business Review

OCTOBER 23, 2014

That’s why pharmaceutical, biotechnology, and medical device companies need to define their relevance in this new health care ecosystem, and soon. They’re also sharing risk. The new business model has yet to solidify, and the leaders have yet to emerge. The positions are there for the taking. But not for long. The options are tangible.

Health Care 8

Health Care Pharmaceuticals Information Technology Supply Chain 8

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

DECEMBER 18, 2014

It used to be that hospitals and health systems operated as islands, selecting and purchasing medical supplies, devices and medications in isolation, and keeping their operational and leadership practices to themselves. While collaboration is always challenging, the health care benefits are by now clear.

Health Care 8

Health Care Retail Mayo Pharmaceuticals 8

Harvard Business Review

APRIL 16, 2012

To enhance financial flexibility, companies have been retaining unprecedented amounts of cash on their balance sheets, calling it "strategic" cash to distinguish it from the "operating" cash that is needed to run the business. high technology or pharmaceutical) that are investing in projects with uncertain long-range payoffs.

Company 15

Company Cost of Capital Finance Long-term 15

Harvard Business Review

NOVEMBER 7, 2017

In all these cases, the antitrust authorities argued that further combinations among firms in the same market would hurt consumers. When two separate firms with market power occupy successive positions in an industry value chain, both will try to earn a profit margin over their costs. Evaluating vertical mergers is trickier.

Health Care 8

Health Care Proposal Insurance B2B 8

Harvard Business Review

MAY 5, 2016

But peruse some of the recent headlines about Iran , and you might wonder whether the market’s potential was overstated. However, despite a weakened economy, political tensions, market uncertainty, and the lingering effects of sanctions, Iran remains an important opportunity for multinationals in emerging markets.

Tourism 8

Tourism Banking Due Diligence Hotels 8